Definition and epidemiology
Social anxiety disorder (SAD), formerly called social phobia, is characterized by marked, persistent fear or anxiety about one or more social situations in which the person is exposed to possible scrutiny by others (e.g., social interactions, being observed, performing in front of others). The person fears acting in a way that will be negatively evaluated, leading to humiliation, embarrassment, or rejection.
- Lifetime prevalence is approximately 7-13% in Western populations, making it one of the most common anxiety disorders and among the most common psychiatric disorders overall.
- Median age of onset is early-to-mid adolescence (often 13 years), with most cases emerging before age 20.
- Slightly more common in women in community samples, though clinical samples show more balanced or male-predominant presentations.
- Often chronic and unremitting without treatment; many patients do not seek care for years due to shame or because they view their anxiety as a personality trait rather than a treatable illness.
- Diagnosis requires symptoms persisting 6 months or more causing significant impairment (DSM-5).
- Median onset is early adolescence; most cases begin before age 20.
- Performance-only subtype responds well to as-needed propranolol before the triggering event.
- CBT with exposure therapy is first-line and has the strongest evidence base.
- Paroxetine, sertraline, fluvoxamine ER, and venlafaxine XR are FDA-approved for SAD; fluoxetine and escitalopram are used off-label.
- Comorbid alcohol use disorder is common, often from self-medicating anticipatory anxiety.
- Avoidant personality disorder overlaps heavily with generalized SAD and is a key differential.
- Benzodiazepines are not first-line long-term due to dependence risk.
Etiology and risk factors
The etiology is multifactorial, involving genetic predisposition, temperament, and environmental learning.
- Genetic/familial: first-degree relatives of affected individuals have higher risk; heritability estimates around 30-50%.
- Temperament: behavioral inhibition in childhood (shyness, withdrawal from novel stimuli) is a strong precursor.
- Environmental factors: overprotective or critical parenting styles, history of bullying or peer rejection, and early humiliating social experiences.
- Neurobiological factors: amygdala hyperreactivity to social threat cues and altered serotonergic and dopaminergic signaling.
- Comorbid conditions: often coexists with other anxiety disorders, major depressive disorder, and substance use disorders (especially alcohol use, which may begin as self-medication for anticipatory anxiety).
Pathophysiology
SAD is thought to arise from dysregulated fear-processing circuitry.
- The amygdala shows exaggerated activation in response to perceived social threat (e.g., critical facial expressions), driving the autonomic fear response.
- The prefrontal cortex, which normally exerts top-down regulatory control over the amygdala, shows reduced inhibitory connectivity, impairing emotional regulation.
- Excess activation of the sympathetic nervous system produces the hallmark somatic symptoms: tachycardia, blushing, sweating, tremor, and gastrointestinal upset.
- Cognitive models emphasize biased information processing: hypervigilance to social threat cues, negative self-focused attention, and anticipatory and post-event rumination that reinforce avoidance behavior.
- Avoidance provides short-term relief but prevents disconfirmation of feared outcomes, perpetuating the disorder (a key rationale for exposure-based therapy).
Clinical features
Core features include marked fear of social or performance situations, nearly always provoking anxiety, and often leading to avoidance.
- Performance-only subtype: fear limited to public speaking or performing (e.g., musicians, surgeons giving presentations).
- Generalized subtype: fear across most social situations (meeting new people, eating/drinking in public, using public restrooms, speaking to authority figures).
- Physical symptoms during exposure: blushing, sweating, trembling, tachycardia, dry mouth, muscle tension, and sometimes panic-attack-like symptoms.
- Cognitive symptoms: fear of being judged as anxious, weak, or foolish; excessive self-consciousness; anticipatory anxiety for days to weeks before an event.
- Behavioral consequences: avoidance of school, work, or social opportunities; use of "safety behaviors" (avoiding eye contact, rehearsing speech, using alcohol before socializing).
- Children may present with crying, tantrums, freezing, or clinging to caregivers rather than verbalized fear.
Diagnosis
Diagnosis is clinical, based on history; no laboratory or imaging studies are required.
DSM-5 criteria (summary)
- Marked fear/anxiety about one or more social situations involving possible scrutiny.
- Fear of acting in a way that will be negatively evaluated.
- Social situations almost always provoke fear/anxiety and are avoided or endured with intense distress.
- Fear is out of proportion to the actual threat and persists for 6 months or more.
- Causes clinically significant distress or impairment in social, occupational, or other functioning.
- Not attributable to a substance, medical condition, or better explained by another mental disorder.
- Specify if performance only.
Screening tools
- Liebowitz Social Anxiety Scale (LSAS): clinician-rated severity measure.
- Social Phobia Inventory (SPIN): self-report screening tool.
- Mini-SPIN: brief 3-item screen useful in primary care.
Rule out underlying medical causes of autonomic symptoms (e.g., hyperthyroidism, pheochromocytoma) only when clinical suspicion exists; routine workup is not indicated.
Differential diagnosis
| Condition | Distinguishing feature |
|---|---|
| Panic disorder | Panic attacks are unexpected, not situationally bound to social scrutiny |
| Agoraphobia | Fear centers on inability to escape or get help, not negative evaluation |
| Generalized anxiety disorder | Worry is broad (health, finances, work), not specific to social scrutiny |
| Avoidant personality disorder | Pervasive, early-onset pattern of social inhibition and inadequacy feelings; significant overlap with generalized SAD |
| Autism spectrum disorder | Social difficulty stems from impaired social communication skills, not fear of judgment despite adequate skills |
| Normal shyness | Does not cause significant impairment or meet duration/severity criteria |
| Body dysmorphic disorder | Avoidance driven by perceived physical defect, not general social evaluation |
| Major depressive disorder with social withdrawal | Withdrawal driven by anhedonia/low energy, not fear of scrutiny |
Management
Guidelines (APA, NICE, WHO mhGAP) converge on cognitive behavioral therapy (CBT) and SSRIs/SNRIs as first-line, often used individually or in combination for moderate-to-severe cases.
Psychotherapy
- CBT (individual or group) is first-line, especially cognitive restructuring combined with graded exposure to feared social situations; strongest evidence base.
- Exposure therapy specifically targets avoidance, allowing disconfirmation of feared outcomes.
- Social skills training may help select patients with skill deficits.
Pharmacotherapy
- SSRIs paroxetine, sertraline, and fluvoxamine (extended-release) and the SNRI venlafaxine (extended-release) are FDA-approved for SAD and considered first-line.
- Fluoxetine and escitalopram are also commonly used and recommended in guidelines as effective SSRI options, but they are not FDA-approved specifically for this indication; their use is off-label.
- Response may take 4-6 weeks; treatment is typically continued for 6-12 months after response before considering taper.
- Beta-blockers (e.g., propranolol) are useful specifically for performance-only subtype, taken as needed before the triggering event to blunt peripheral autonomic symptoms (tremor, tachycardia); not effective for generalized SAD.
- Benzodiazepines may be used short-term for acute severe anxiety but are avoided long-term due to dependence risk; generally reserved for refractory cases or short bridging periods.
- MAOIs (e.g., phenelzine) are effective but reserved as second/third-line due to dietary restrictions and side-effect burden.
- Combination of CBT plus medication may be considered for severe or treatment-resistant presentations.
NICE and APA both emphasize psychotherapy as preferred first step for mild-to-moderate disease, with pharmacotherapy added or substituted for moderate-to-severe disease or patient preference.
Complications and prognosis
- Without treatment, SAD tends to follow a chronic, unremitting course; spontaneous remission is uncommon.
- Increased risk of comorbid major depression, other anxiety disorders, and substance use disorders, particularly alcohol use disorder from self-medication.
- Significant impact on educational attainment, career advancement, and romantic relationships due to avoidance behaviors.
- Elevated risk of suicidal ideation, particularly when comorbid depression is present.
- With appropriate CBT and/or pharmacotherapy, most patients achieve meaningful symptom reduction, though relapse is common if treatment is stopped prematurely.
- Early identification and treatment in adolescence improves long-term functional outcomes and may reduce the risk of secondary depression and substance use.
FEAR: Feared social situations, Embarrassment/humiliation anticipated, Avoidance or endurance with distress, Recognized as excessive, lasting 6+ months.
Practice questions
1. A 19-year-old college student avoids group presentations and eating in the dining hall because he fears others will notice him sweating and judge him as incompetent. He has had these symptoms since age 14, and they prevent him from attending required seminar classes. He has no panic attacks outside social settings and no fear of being trapped in enclosed spaces. Which of the following is the most likely diagnosis?
2. A 28-year-old violinist experiences severe hand tremors, tachycardia, and nausea only before orchestral performances, but reports no anxiety in everyday social interactions such as dining out or meeting new colleagues. Which treatment is most appropriate to take shortly before a performance?
3. A 24-year-old woman with longstanding social anxiety disorder has been using alcohol before social gatherings for the past 3 years to "calm her nerves" and now meets criteria for alcohol use disorder. Which of the following best explains this comorbidity pattern?
Frequently asked questions
What causes social anxiety disorder?
Social anxiety disorder arises from a combination of genetic predisposition, inhibited temperament, and environmental factors such as critical parenting or early social humiliation. Neurobiologically, it involves amygdala hyperreactivity to perceived social threat combined with reduced prefrontal regulation. No single cause explains all cases; it is best understood as a gene-environment interaction affecting fear-processing circuits.
What are the first symptoms of social anxiety disorder?
Early symptoms usually include intense anticipatory worry before social events, physical signs like blushing, sweating, trembling, or a racing heart during interactions, and a strong urge to avoid or escape situations involving scrutiny. In adolescents, this may present as school avoidance or reluctance to speak in class. Symptoms typically emerge in early-to-mid adolescence and worsen without treatment.
How is social anxiety disorder diagnosed?
Diagnosis is clinical, based on a detailed history matching DSM-5 criteria: marked fear of social scrutiny lasting 6 months or more with significant distress or impairment. No lab tests or imaging are required. Clinicians often use screening tools like the Liebowitz Social Anxiety Scale or Social Phobia Inventory to assess severity and track treatment response.
Is social anxiety disorder curable?
Social anxiety disorder is not typically described as curable but is highly treatable, with most patients achieving substantial and lasting symptom improvement through CBT, medication, or both. Many people reach a point of full functional recovery, though some retain mild residual anxiety in specific situations. Relapse is more likely if treatment is stopped abruptly or incompletely.
Social anxiety disorder vs avoidant personality disorder — what is the difference?
Social anxiety disorder is an anxiety disorder centered on fear of negative evaluation in specific social or performance situations, while avoidant personality disorder is a pervasive, early-onset personality pattern of social inhibition, feelings of inadequacy, and hypersensitivity to criticism across nearly all contexts. The two overlap substantially, and some clinicians view severe generalized SAD and avoidant personality disorder as existing on a spectrum rather than being fully distinct.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: F40.1
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.